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Cyclic AMP-dependent protein kinase isozymes of pig 
and human skin (epidermis) were separated by DEAE-
cellulose column chromatography after micromodifica- . 
tion for small biopsy samples. Clear-cut separations of 
type I and type IT isozymes, which were of about equal 
amounts, could be obtained only when the ischemi& ef-
fect was avoided by in vivo freezing .onikin and homog-
enization for less than 10 s. Ip.tradermal injections of 
epinephrine caused dose-dependent activation of type I 
isozyme, but not of type IT. Injections of other skin ade-
nylate cyclase stimulators such as histamine, adenosine, 
and prostaglandin E2 elevated the local cyclic AMP levels 
to not more than 5 pmol/mg protein and also stimulated 
only the type I isozyme. 
Incubation of keratome-sliced pig skin under various 
conditions caused both activation by dissociation and 
inactivation by reassociation of the subunits, which ap-
peared to be dependent on the cyclic AMP content. Epi-
nephrine added to the incubation medium led to com-
plete activation of both type I and type IT isozymes (the 
intraepidermal cyclic AMP contents ranged from 20-50 
pmol/mg protein). 
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Abbreviations: 
cyclic AMP: cyclic adenosine 3',5'-monophosphate 
EGTA: ethyleneglycol-bis-(f3-aminoethyl ether)-N,N' -tetraacetic 
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IBMX: isobutylmethylxanthine 
PGE2: prostaglandin E, 
The isozymes of normal skin and involved skin of 
psoriatics showed identical peaks of type I and type IT 
isozymes of equal amounts. The data indicate that pro-
tein kinase in the involved skin is not in an activated (by 
cyclic AMP) state. 
Activation of the cyclic AMP system by hormones or other 
chemicals is followed by a specific phosphorylation process 
mediated by cyclic AMP-dependent protein kinase. Since the 
physiologic effects of an increase in cyclic AMP are solely 
dependent on this activation process, cyclic AMP-dependent 
protein kinase activity may be more important than the increase 
in cyclic AMP level itself. Cyclic AMP-dependent protein ki-
nase has 2 regulatory and 2 catalytic subunits [1]. The inactive 
holoenzyme dissociates in the presence of cyclic AMP into the 
active catalytic subunit and the regulatory subunit-cyclic AMP 
complex [2]. Since Reimann et al [3] f!l'st demonstrated two 
different types of cAMP-dependent protein kinase, these iso-
zymes (types I and II) have been found in most mammalian 
tissues [2-7). These two isozymes have the same catalytic 
subunit, although the regulatory subunits are different [8]. 
Type I and type II isozymes can be separated by DEAE-
cellulose column chromatography [1,4], i.e., a free catalytic 
subunit can be eluted by 10 mM potassium phosphate buffer, 
and type I and type II isozymes by 0.1 and 0.2 M of NaCI, 
respectively. Type I kinase can be rapidly dissociated into the 
free regulatory and catalytic subunits by salt or substrate. 
These subunits will slowly reassociate by removing the disso-
ciating agents. In contrast, type II kinase can be only slowly 
dissociated but will rapidly reassociate [2,9). 
It appears that these isozymes have specific functions in some 
tissues. Byus et al [10] showed t hat glycogenolysis in rat hepa-
tocytes was regulated by the activation of type I kinase. Costa 
et al [11] reported that type I kinase activity was high in mitosis 
while type II kinase activity was associated with the S phase of 
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cell division. Olson and Russell [12] demonstrated that the 
activation of type I kinase led to ornithine decarboxylase in-
duction. As far as skin is concerned, Kumar et al [13] have 
demonstrated the isozymes in monkey and human skin, but the 
physiologic function of each isozyme is still not clear. In this 
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study, we measured activation of type I and type II isozymes of 10,000 cpm 
pig and human skin in relation to the activation of adenylate 
cyclase. With micromodification of our analytical system, we 
also measured the isozymes in the involved skin of psoriatics. 
MATERIALS AND METHODS 
Histone H II A was obtained from S igma and both DE-52 a nd 
phosphocellulose paper (P 81) were products of What ma n. [ y-""PJ-ATP 
was purchased from Amersham. 
Shin Treatment 
Domestic pigs weighing a bou t 6 to 8 kg were anesthetized with 
Nembutal i.p. (30 mg/ kg). For in vitro studies, skin samples were taken 
with a keratome set at 0.2 mm in th ickness. The skin pieces composed 
of 80-85% epidermis were incubated in Ha nks' medium as described in 
the following section. For in vivo studies, several concentrations of 
epinephrine hydrochloride in saline (0.5 ml each) were injected intra-
dermally in to the back skin of pigs with a tuberculin syringe. After 10 
min, the injected s ites were fTozen with dry ice and removed with the 
keratome. Saline-injected skin was removed in an identical manner. 
Human skin samples, about 5 mm square, were obtained fTom normal 
subjects a nd lesional skin of psoriasis patients by shave biopsy [14] 
after freezing the skin with liquid nitrogen spray. All samples were kept 
in a deep freezer until use. 
Cyclic AMP Measurement 
The cyclic AMP contents in the shave biopsy samples at 5 min 
after the int radermal injections (0.5 ml each) of epinephrine (0.5 
mM) , histamine (10 mM), adenosine (10 mM), and PGE2 (0.5 mM) 
were measured by a radioimmunoassay method with s light modifi -
cation [14]. 
DEAE-Cellulose Column: 
DE 52 column procedures were as described by Corbin and Keely 
[4]. The skin samples kept in a deep freezer were cut into 5-mm squares 
with scissors as they were frozen, and homogenized for 5 s twice in 1-3 
ml of cold 10 mM potassium phosphate buffer, pH 6.8, containing 1 mM 
EDTA in a glass homogenizer. The homogenate was centrifuged for 30 
min at 30,000 x g, and the supernatant (generally 3-6 mg protein with 
specific activity of 150-200 pmol/mg protein/ min) was applied to a 
DEAE-cellulose column (0.6 x 4 cm) equilibrated with the same buffe r. 
After washing the column with 10 ml of the buffer, the isozymes were 
collected each in 300-111 fTactions by a linear NaCI gradient (0-400 mM). 
The flow rate was 50 Ill/min. The variation of the chTomatographs was 
less than 10%. 
Cyclic AMP-Dependent Protein Kinase Assay: 
The reagent mixture consisted of 100 Ilg/50 III of histone H IIA, 10 
mM potassium phosphate buffer pH 6.8,10 mM NaF, 10 mM magnesium 
acetate, 0.25 mM EGTA, 0.1 mM IBMX, 20 IlM ATP (conta ining 0.5-1 
IlCi of [ y-:\~P]-A TP, approximately 8 x 10" cpm) , 5 IlM cyclic AMP 
(when added), and the isozymes (20 Ill) in a total volume of 50 Ill. The 
reaction was stru·ted by adding the isozymes from the fTactions, and the 
mixtures were in cubated at 30°C for 5 min. After the incubation, 40 III 
each of the mixtures were applied on 2 x 2 em pieces of phosphocel-
lulose paper and washed with tap water for 1 h. These papers were· 
dehydrated with acetone a nd counted in a liquid scintillation counter. 
The protein kinase activities were expressed as tota l :\2p incorporated 
in cpm/5 min (at 30°C)/20 III each from fractions obtained through the 
DEAE-cellulose column. Because of rapid decay of ""p, the cpm values 
were corrected for those on day 1. The initial crude enzyme applied 
onto the column varied from 3-6 mg protein, hence the prote in kinase 
activities were corrected for 5 mg initial protein. 
RESULTS 
A typical separation of type I and type II isozymes of pig skin 
protein kinase is shown in Fig 1A. Reproducible separation of 
the isozymes could be obtained when skin samples were re-
moved after the skin surfaces had been frozen with dry ice and 
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FIG 1. Chl'Omatographic separation of cyclic AMP-dependent pro-
tei n kinase isozymes 0(' pig skin. A , A typical isozyme pattern shows 
type I and type II peaks. The enzyme activity (cpm) is shown in 
ordinate, the elution tube number is shown in abscissa. A lineal' NaCI 
gradient to 400 mM stru·ted at tube No. 21. B, The isozyme pattern after 
partia l ischemia. The skin sample was obtained without in vivo freezing 
and left in the air for 1 min. Note partial activation of type I isozyme 
(i.e. , partial decrease of peak I) and the a ppearance of a new peak at 
tubes No. 5- 7. This peak "C" is the cataly tic subunit. Dotted line 
indicates the enzyme activity in the absence of cyclic AMP in the assay 
mixtUl'e. C, The isozy me pattern a fter 5 min of ischemia. Note mru'ked 
activation of both type I and type II isozymes. D, The effects of 
preincubation. The skin sample left in the a il' for 5 min was incubated 
in Hanks' balanced salt solu tion with 200 mg/ 100 cc glucose for 20 min 
prior to homogenization. Note the recovery of both peaks due to the 
reassociation of regulatory and catalytic subunits. 
skin samples were left at room temperature for 1 min, the 
resulting ischemia effect [15] caused a substantial loss of the 
type I isozyme peak; after 5 min of the ischemia, both type I 
and type II peaks were lost (Fig IB,C). The losses were due to 
the activation of both isozymes by sudden elevation of cyclic 
AMP levels after skin removal (ischemia). Fig IE shows that 
the catalytic unit, free from the regulatory unit, was eluted at 
the early fractions (c.f., the elution tube #5-#7). Fig IE also 
shows that the act.ivated catalytic subunit was no longer cyclic 
AMP-dependent, whereas the type I and type II isozymes were 
still cyclic AMP-dependent. The losses of the two isozyme 
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peaks could be restored by incubating the keratomed skin 
samples in Hanks' medium for 15-20 min at 37°C prior to 
homogenization (Fig ID). 
Fig 2 summarizes the results of in vivo activation experiments 
after epinephrine intradermal injections into pig skin. Skin 
samples were removed after in vivo freezing by dry ice. The 
results clearly indicate that type I isozyme was activated in a 
dose-dependent manner, but type II isozyme was not activated. 










FIG 2. An in vivo activation: effects of in tradermal injections of 
epinephrine on the isozyme patterns. T he epinephrine injections were 
0.5 ml each of 20 f.Lg/ ml (A), 100 f.Lg/ m l (B) , and 1000 f.Lg/ ml (C). For 




FIG 3. The in vivo activation with PGE". PGE" (0.5 mM) was injected 
intradermally. The dashed line shows a contro l pattern. Neruoly iden-
tical patterns were obtained with the in tradermal injections of hista-
mine (10 mM) and adenosine (10 mM) . 
10,000 cpm 
5,000 









FIG 4. In vitro activat ion: effects of epinephJ'ine added to the me-
dium. The skin s lices were preincubated for 20 min to eliminate the 
ischemia effect and subsequently transferred to medium containing 5 
X 10-" M epinephJ'ine for 5 min. Dashed line indicates the control 













FIG 5. The chromatographic separation of type I and type II iso-
zymes of human skin protein kinase. A, Normal skin of normal subject. 
B, T he involved skin of psoriatics. The shave biopsies of skin samples 
(5 x 5 mm) were obtained after freezing the skin surface with liquid 
nitrogen spray. 
about 5 pmol/mg protein as compared with normal value of less 
than 1 pmol/mg protein. 
The effects of intradermal injections of other skin cyclic 
adenylate cyclase stimulators such as histamine [16], adenosine 
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[17], and PGE2 [18] were also examined. Determinations on 
cyclic AMP contents in triplicate samples showed increased 
levels up to 5 pmol/mg protein after the injections. Fig 3 shows 
the effect of PGE2 injection. Partial activation of only type I 
isozyme occuned. This is similar to the in vivo injection of 
epinephrine (Fig 2). The effects of adenosine and histamine 
were identical to the above and thus the results are not shown 
here. 
The loss of type II isozyme peak was easily observed when 
the keratomed skin was incubated in vitro with epinephrine. 
Fig 4 shows one such experiment. Keratomed skin was prein-
cubated in a physiologic medium for 20 min to restore both 
isozyme peaks and then transfened to the medium containing 
epinephrine. The complete loss of both peaks was evident. 
The isozyme patterns of protein kinase from human skin are 
shown in Fig 5. Both normal skin from normal subjects and the 
involved skin of psoriasis patients revealed clear-cut separation 
of type I and type II isozyme peaks which were of equal 
amounts. 
DISCUSSION 
Since Corbin et al [2] reported the occunence of two protein 
kinase isozymes that could be distinguished on the basis of 
DEAE-ceLlulose elution profiles, similar isozymes have been 
separated from many tissues and organs including fat, heart, 
skeletal muscle, liver, kidney, brain, salivary gland, ovary, etc. 
[2-7]. The separation of 2 isozymes from both pig and human 
skin as presented in this study is also consistent with data from 
other tissues. Kumar et al [13] reported the occunence of 3 
peaks of human skin protein kinase, whereas we consistently 
isolated only 2 peaks. The reason for this discrepancy is un-
known. However, reviewing their data, their peaks II and III 
may be one peak, peak II, since the separation is not complete. 
Another possibility is that their starting samples might have 
consisted of whole-thickness skin and subcutaneous tissue, in 
contrast to ours which were predominantly epidermis. The 
mixture of epidermis, dermis, and fat might have caused the 
slight spli tting of peak II. 
During the early stages of our studies, when we minced and 
homogenized tissue thoroughly, the chromatographic separa-
tions of isozymes were often erratic and unreproducible. Sub-
sequently, we found that the rise in cyclic AMP in skin due to 
the ischemia effect caused artifactual shifts in the isozyme 
peaks. The ischemia effect can be prevented by routinely freez-
ing skin in vivo before sampling, and also the samples should 
be homogenized for not longer than 10 s. In other experiments 
we found that the in vivo freezing abolished the ischemia effect 
(unpublished data). The precaution of not over-homogenizing 
tissue has also been recommended for total skin protein kinase 
assays [19]. 
A loss in isozyme peak I (i.e., the dissociation of regulatory 
and catalytic subunits) appears to conelate with the cyclic 
AMP contents, since the degree of loss was dependent on the 
dosages of epinephrine injected intradermally. The intradermal 
injections of other skin adenylate cyclase stimulators such as 
histamine, PGE2, and adenosine also activated the type I sub-
unit, but not the type II. The injections of these stimulators 
caused increases in intraepidermal cyclic AMP levels up to 5 
pmol/mg protein [20]. The higher cyclic AMP level associated 
with ischemia for 5 min (but not for 1 min) caused activation of 
both type I and type II subunits. Our previous studies [15] 
sho.wed that the cyclic AMp 'levels at 1 min of ischemia ranged 
from 3-5 pmol/mg dry weight, whereas the level at 5 min 
reached 10 pmol/mg dry weight. 
Preincubation of the keratomed slices in a physiologic me-
dium caused reassociation of the regulatory and catalytic sub-
units (as indicated by the restoration of two peaks, Fig ID). 
These data are consistent with the fact that the preincubation 
caused a decrease in the cyclic AMP level to 2 pmol/mg protein 
which is close to an unstimulated in vivo level [21]. Further 
incubation of the skin slice with epinephrine led to complete 
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activation (thus dissociation) of both peak I and peak II which 
was shown as losses of both peaks (Fig 4) . In this in vitro 
experiment, the intracellular cyclic AMP levels range from 20-
50 pmol/mg protein after epineplu'ine stimulation [21]. 
It has been shown that adenylate cyclase in the lesional skin 
of psoriatics responds poorly to epinephrine stimulation as 
compared with normal skin [22,23]. In search of another abnor-
mality in the cyclic AMP cascade we have looked for an 
abnormal protein kinase activity ratio but the ratios were nearly 
identical among normal skin and uninvolved and involved skin 
of psoriatics [24]. The cunent protein kinase isozyme study 
also fails to detect any basic abnormality in the involved skin. 
Costa et al [11] showed that during the mitotic stage of Chinese 
hamster ovary cells, the activity of type I isozyme became 
maximal, but that of type II minin1al. The psoriasis lesion 
where mitosis is markedly increased might have shown a pre-
dominant type I isozyme, but we found no change in the 
isozyme pattern. However, since intraepidermal cyclic AMP 
levels are about the same in normal skin and in uninvolved and 
involved epidermis of psoriatics [14,25], we should not expect 
any change in either protein kinase activity ratio or its isozyme 
pattern. Our data support the view that the epidermis as an 
organ has a proper homeostatic control system with regard to 
protein kinase. In both normal and psoriatic skin including the 
les ion, protein kinase is in a nonactivated state ready to respond 
to any increase in cyclic AMP. At any rate, the biochemical 
abnormality in psoriasis thus far appears to be limited to the 
,B-adrenergic membrane receptor unit of the lesional skin. 
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Local Effects of Synthetic Leukotrienes (LTC4, LTD4 , LTE4 , and LTB4 ) in 
Human Skin 
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The local effects of intracutaneous injections into hu-
mans of 1-3 nmol of five products of arachidonic acid 
metabolism, leukotrienes (LT) C4, D." E." a nd B4 from the 
5-lipoxygenase pathways and prostaglandin (PG) D2 
from the cyclooxygenase pathway, were assessed clini-
cally and histologically. In equimolar concentrations, 
LTC4, LTD4, and LTE4 elicited erythema and wheal for-
mation, in which a wheal with central pallor was present 
up to 2 hr, and the erythema p ersisted as long as 6 hr. 
PGD2 elicited a wheal that lasted up to 1 hr and erythema 
that lasted up to 2 hr. The dermal vascular site s affected 
by LTD4 and PGD2 included capillaries, superficial and 
deep venules, and arterioles. L TB4 elicited a transient 
wheal and flare, followed in 3-4 hr by induration that 
was characterized by a d e rmal infiltrate comprise d pre -
dominantly ofneutrophils. The combination ofLTB4 and 
PGD2 elicited tenderness and increased induration as-
sociated with a more intense neutrophil infiltration. 
Thus, the products of the 5-lipoxygenase pathway of 
arachidonic acid m e tabolism in nanomole amounts can 
induce cutaneous vasodilation with e d ema forma tion 
and a neutrophil infiltrate, and these responses are en-
hanced by a cyclooxygenase pathway product, PGD2 • 
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Abbreviations: 
L T: leukotriene 
P G: prostaglandin 
SRS-A: slow reacting substance of anaphylaxis 
The oxidative products of arachidonic acid appearing with 
physiologic and pathobiologic per turbations of cellular mem-
brane phospholipids include the prostaglandins, throm boxane, 
a nd t he leukotrienes. P rostagla ndin (PG) D 2, the predominant 
product of arachidonic acid metabolism in human mast cells in 
vi tro [1,2] and in vivo [3,4], a nd leukotrienes (LT ) C., D., and 
K, [5-9], recognized as components of slow reacting substance 
of anaphylaxis (SRS-A) , are considered among the mediators 
of acute allergic processes. 
Knowledge of the cutaneous effects of the L T components of 
SRS-A is limited to observations of alterations in venular 
permeability in guinea pigs [6,10,11] and rats [11], but not 
ra bbits [11], a nd the morphologic dem onstration of dilated 
superficial and deep blood vessels in monkey skin (12). PGD2, 
a metabolite of the cyclooxygenase pathway of arachidonic 
acid, can produce vasodilation in rat skin and elicit a wheal and 
erythema r eaction in human skin (13). L TB4, a potent che-
moattractant [14] that elicits a neutrophil inflltrate in monkey 
skin [15], is inactive in the rabbit skin unless combined with a 
vasodila ting prostaglandin (16). Inasmuch as there is no infor-
mation on the cutaneous effects in humans of the leukotrienes 
alone or in combination with PGD 2, the intracutaneous injec-
tion of LTG" LTD., L TK" PGD 2, and L T B. alone and in some 
combinations was assessed by clinical and histologic paJ'am e-
tel's. 
MATERIALS AND METH ODS 
LTG" LTD., LTE., , PGDz, and LT B., were prepared as previously 
described [8,17-20] and stored frozen at a concentration of 25 /Lg/ m l in 
0.1 M phosphate buffe r (pH 6.8l :ethanol (4:1, v/ v) under argon un til 
the day of use. Immediately before inj ection these substances were 
dried under argon and then redissolved in 0. 1 ml of a sterile solu tion 
containing 0.15 M NaCI wi th 2% ethanol.. LT G, (1.0 nmol/site), LTD" 
(1.0 nmol/site), LTE., (1.0 nmol/site) , PGD2 (3.0 nmol/site) , LTB. (1.6 
nmol/site), and vehicle alone or in vaJ·ious comb.inations were coded 
and injected intradermally into the ventral aspects of the forear ms of 
3 adult ma le volunteers after informed consent was obtained. Clinical 
